Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRE-EMPT in Suicidal Ideation
NCT07484906Phase 2Withdrawn
- Sponsor
- The University of New Mexico
- Start
- May 2026
- Primary completion
- Aug 2029
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of psilocybin in suicidal ideation, sponsored by The University of New Mexico. Planned start May 2026; status: withdrawn.
02
Drugs
psilocybin
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT07484906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07484906.